COM:ONCONOVA
Onconova Therapeutics, Inc.
- Stock
Last Close
1.00
02/04 20:00
Market Cap
20.90M
Beta: -
Volume Today
1.25M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -62.56M - | -63.80M 1.98% | -24.02M 62.34% | -19.67M 18.13% | -24.09M 22.50% | -20.41M 15.28% | -21.50M 5.36% | -25.16M 16.99% | -16.16M 35.75% | -18.96M 17.33% | -18.95T 99,915,529.61% | |
depreciation and amortization | 446K - | 434K 2.69% | 150K 65.44% | 96K 36% | 88K 8.33% | 55K 37.50% | 14K 74.55% | 13K 7.14% | 14K 7.69% | 14K 0% | 16B 114,285,614.29% | |
deferred income tax | -42K - | -20K 52.38% | 44K 320% | -163K - | -98K - | |||||||
stock based compensation | 8.02M - | 5.07M 36.77% | 3.79M 25.30% | 3.93M 3.78% | 1.71M 56.48% | 1.15M 32.92% | 1.05M 8.63% | 369K 64.79% | 576K 56.10% | 1.17M 103.47% | 1.30T 111,006,725.94% | |
change in working capital | -7.24M - | 671K 109.26% | -11.17M 1,765.13% | 3.82M 134.16% | 102K 97.33% | -1.07M 1,146.08% | -327K 69.35% | 1.49M 556.27% | -3.59M 340.82% | 1.48M 141.30% | 1.77T 119,272,137.20% | |
accounts receivables | -1.37M - | 1.47M 207.36% | -28B 1,900,982.55% | 24B 185.71% | -63B 362.50% | 61K 100.00% | 9B 14,753,998.36% | -1K 100.00% | 11B 1,100,000,100% | |||
inventory | -814K - | 897K 210.20% | 28.00B 3,121,381.94% | -24.00B 185.71% | 63B 362.51% | -61K 100.00% | -9B 14,753,998.36% | |||||
accounts payables | -1.81M - | 317K 117.54% | -606K 291.17% | 1.90M 413.86% | 863K 54.63% | -1.45M 268.48% | 232K 115.96% | 562K 142.24% | -2.08M 469.40% | 1.10M 153.13% | 1.76T 159,474,061.38% | |
other working capital | -5.44M - | 354K 106.51% | -8.38M 2,467.51% | -455K 94.57% | -454K 0.22% | -398K 12.33% | -559K 40.45% | 930K 266.37% | -1.52M 263.12% | 382K 125.18% | -1.77T 463,350,885.34% | |
other non cash items | -4K - | -6K 50% | -22K 266.67% | -3.99M 18,027.27% | -1.63M 59.18% | -2.26M 38.70% | -63K 97.21% | 208K 430.16% | -321K 254.33% | 98K 130.53% | -301B 307,142,957.14% | |
net cash provided by operating activities | -61.38M - | -57.65M 6.09% | -31.24M 45.81% | -15.81M 49.38% | -23.82M 50.64% | -22.70M 4.72% | -20.83M 8.22% | -23.07M 10.77% | -19.49M 15.55% | -16.29M 16.39% | -17.93T 110,052,680.16% | |
investments in property plant and equipment | -609K - | -228K 62.56% | -55K - | -15K 72.73% | -14B - | |||||||
acquisitions net | ||||||||||||
purchases of investments | -39.99M - | |||||||||||
sales maturities of investments | 40M - | |||||||||||
other investing activites | ||||||||||||
net cash used for investing activites | -40.60M - | 39.77M 197.96% | -55K - | -15K 72.73% | -14B - | |||||||
debt repayment | ||||||||||||
common stock issued | 79.81M - | 7.46M - | 17.42M 133.39% | 6.36M 63.49% | 35.07M 451.38% | 21.76M 37.95% | 9.06M 58.35% | 55.04M 507.38% | ||||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 653K - | 1.46M 124.04% | 3K - | 589K - | 4.89M 730.05% | 10.29M 110.57% | 519K 94.96% | |||||
net cash used provided by financing activities | 80.46M - | 1.46M 98.18% | 7.46M 410.18% | 17.42M 133.43% | 6.36M 63.50% | 35.66M 460.64% | 26.65M 25.27% | 19.36M 27.36% | 55.56M 187.03% | |||
effect of forex changes on cash | 1K - | -14K 1,500% | -9K 35.71% | -9K 0% | 34K 477.78% | -15K 144.12% | -6K 60% | 32K 633.33% | -28K 187.50% | -19K 32.14% | ||
net change in cash | -21.52M - | -16.43M 23.66% | -23.78M 44.78% | 1.60M 106.73% | -17.43M 1,188.44% | 12.95M 174.29% | 5.76M 55.54% | -3.70M 164.30% | 36.05M 1,073.93% | -16.31M 145.26% | -17.94T 109,949,020.33% | |
cash at beginning of period | 81.53M - | 60.01M 26.39% | 43.58M 27.37% | 19.80M 54.57% | 21.45M 8.34% | 4.02M 81.24% | 16.97M 321.72% | 22.73M 33.92% | 19.02M 16.29% | 55.07M 189.46% | 38.76T 70,377,601.11% | |
cash at end of period | 60.01M - | 43.58M 27.37% | 19.80M 54.57% | 21.40M 8.09% | 4.02M 81.20% | 16.97M 321.72% | 22.73M 33.92% | 19.02M 16.29% | 55.07M 189.46% | 38.76M 29.62% | 20.82T 53,721,808.30% | |
operating cash flow | -61.38M - | -57.65M 6.09% | -31.24M 45.81% | -15.81M 49.38% | -23.82M 50.64% | -22.70M 4.72% | -20.83M 8.22% | -23.07M 10.77% | -19.49M 15.55% | -16.29M 16.39% | -17.93T 110,052,680.16% | |
capital expenditure | -609K - | -228K 62.56% | -55K - | -15K 72.73% | -14B - | |||||||
free cash flow | -61.99M - | -57.88M 6.64% | -31.24M 46.03% | -15.81M 49.38% | -23.82M 50.64% | -22.70M 4.72% | -20.89M 7.97% | -23.09M 10.55% | -19.49M 15.60% | -16.29M 16.39% | -17.95T 110,138,601.36% |
All numbers in USD (except ratios and percentages)